GLICKMAN MARK A (Chief Business Officer) sold 25.4% of their position (440.00 shares) of THERAPEUTICSMD, INC. on the open market
Open‑market sale worth $2.2K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/9/2022ACC: 0001209191-22-060586
Officer· Chief Business Officer
Since Oct 2021
-440.00
Net shares
Net seller
$2.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.73K acquired · 2.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.73K
Price / share
—
Trade value
—
% of position
New position
12/6/2022
0.00→1.73K
Common Stock
Direct
Shares
−440.00
Price / share
$4.92
Trade value
$2.17K
% of position
25.4%
12/6/2022
1.73K→1.29K
Total
Net shares
+1.29K
Net value
-$2.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/6/2022 | M · Option Exercise | +1.73K | — | — | New position | 0.00 | 1.73K |
| Common Stock Direct | 12/6/2022 | S · Sale | −440.00 | $4.92 | $2.17K | 25.4% | 1.73K | 1.29K |
| Total | +1.29K | -$2.17K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
1.73K shares
Shares
−1.73K
Strike price
0.00
Held after
3.47K
Exercisable
—
12/6/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock1.73K shares | 12/6/2022 | M · Option Exercise | −1.73K | 0.00 | — | 3.47K |